SEC Filings | Portage Biotech

View all our SEC Filings

Filing date	Description	Form	Filing Group	View
Mar 26, 2021	Amendment to a previously filed 20-F	20-F/A	Annual Filings	0001062993-21-003012.pdf 0001062993-21-003012.rtf 0001062993-21-003012.xls View HTML
Mar 8, 2021	Form of prospectus filed in connection with primary offering of securities on a delayed basis	424B2	Registration Statements	0001062993-21-002464.pdf 0001062993-21-002464.rtf 0001062993-21-002464.xls View HTML
Mar 8, 2021	Form of prospectus disclosing information, facts, events covered in both forms 424B2, 424B3	424B5	Registration Statements	0001062993-21-002466.pdf 0001062993-21-002466.rtf 0001062993-21-002466.xls View HTML
Mar 8, 2021	EFFECT	EFFECT	Other	9999999995-21-000867.pdf 9999999995-21-000867.rtf 9999999995-21-000867.xls View HTML
Mar 5, 2021	CORRESP	CORRESP	Other	0001062993-21-002399.pdf 0001062993-21-002399.rtf 0001062993-21-002399.xls View HTML
Mar 5, 2021	CORRESP	CORRESP	Other	0001062993-21-002401.pdf 0001062993-21-002401.rtf 0001062993-21-002401.xls View HTML
Mar 4, 2021	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001062993-21-002333.pdf 0001062993-21-002333.rtf 0001062993-21-002333.xls View HTML
Mar 4, 2021	UPLOAD	UPLOAD	Other	0000000000-21-002613.pdf 0000000000-21-002613.rtf View HTML
Mar 2, 2021	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001062993-21-002106.pdf 0001062993-21-002106.rtf 0001062993-21-002106.xls View HTML
Mar 1, 2021	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	6-K	Current Reports	0001062993-21-002077.pdf 0001062993-21-002077.rtf 0001062993-21-002077.xls View HTML

Data provided by Kaleidoscope.